Epizyme Story

Epizyme Inc -- USA Stock  

USD 18.55  0.30  1.59%

Macroaxis does not monitor all media channels or aggregates social signals for Epizyme. But even though we do not provide professional-grade financial sentiment analysis on Epizyme Inc, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Epizyme. Additionally see Epizyme Hype Analysis, Epizyme Correlation and Epizyme Performance
Purchase by Baskett Forest of 40921 shares of Epizyme
Filed transaction by Epizyme Inc executive. General open market or private purchase of non-derivative or derivative security

Epizyme Inc insider trading alert for perchase of common stock by Baskett Forest, the corporate stakeholder, on March 13, 2018. This event was filed by Epizyme Inc with SEC on 2013-11-18. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This media report from MacroaxisInsider distributed on March 13, 2018 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 3.15% . The overall trading delta when the story was published against the current closing price is 1.31% .

Similar stores for Epizyme

Epizyme Upgraded to Buy at Zacks Investment Researchnews
The Lincolnian OnlineForesite Capital Management Ii Lifted Epizyme Holding By 1.11 Million Ambarella Ordinary Shares AMBA ... Herald KSFull coverage
few days ago at www.macroaxis.com 
Purchase by Weller Harry R of 400000 shares of Epizyme
Macroaxis News
Filed transaction by Epizyme Inc executive. General open market or private purchase of non-derivative or derivative security
over a week ago at http://reurope.com 
As United Therapeutics Corp Del Market Value Declined, Holder Palo Alto Investors LLC Has Decreased ...
ReuropeAs United Therapeutics Corp Del Share Value Declined, Holder Palo Alto Investors LLC Decreased Holding Gldmn Blg Full coverage

Did you try this?

Run Pair Correlation Now

Pair Correlation

Compare performance and examine historical correlation between any two equity instruments
Hide  View All  NextLaunch Pair Correlation


Revenue Comparative Analysis
      Epizyme Comparables 
Epizyme is currently under evaluation in revenue category among related companies. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.